ANALYSIS OF THE CONDITION OF NEWBORNS BORN TO MOTHERS INFECTED WITH CORONAVIRUS

Abstract

One of the current problems of modern obstetrics is the diagnosis, treatment and prevention of intrauterine growth retardation. This pathology ranks second after prematurity among the causes of low-birth-weight babies. The prevalence of fetal retardation varies worldwide from 6.5 to 30.0% of all births, of which about 23% are very low birthweight and about 38% extremely low birthweight babies. A new coronavirus infection, caused by the viral pathogen SARS-CoV-2, which contributes to thrombotic microangiopathy in combination with hypercoagulation syndrome, is currently ongoing. During physiological pregnancy, there is known to be an increased risk of complications associated with both bleeding and thrombosis, which are affected by changes in fibrinolytic activity and hypercoagulable state, endothelial dysfunction, and changes in blood rheological properties. It significantly increases the risk of pregnancy complications such as pre-eclampsia, placental insufficiency, fetal hypoxia, and therefore leads to intrauterine growth retardation of the fetus. This study analyzed the status of newborn babies and the incidence of intrauterine growth retardation in women who had contracted coronavirus infection. Two groups of women were included in study: the first included those who became pregnant 3 to 6 months after a new coronavirus infection, and the second was a control group. The study found that women in the first group were more likely to have pre-eclampsia and their babies were more likely to be diagnosed with intrauterine growth retardation.